Suppr超能文献

肿瘤坏死因子:一种由活化巨噬细胞杀死肿瘤细胞的强效效应分子。

Tumor necrosis factor: a potent effector molecule for tumor cell killing by activated macrophages.

作者信息

Urban J L, Shepard H M, Rothstein J L, Sugarman B J, Schreiber H

出版信息

Proc Natl Acad Sci U S A. 1986 Jul;83(14):5233-7. doi: 10.1073/pnas.83.14.5233.

Abstract

Activated macrophages (aM phi) destroy more effectively cancer cells than normal cells. The mechanism by which macrophages destroy cancer cells is not known. We report here that tumor cells susceptible to aM phi were killed by recombinant (r) tumor necrosis factor type alpha (TNF-alpha), whereas variant tumor cells resistant to aM phi after selection in vitro or in vivo were resistant to killing by rTNF-alpha. The converse selection for rTNF-alpha-resistant variants resulted in cells that were also resistant to killing by aM phi. The sensitivity of macrophage-resistant variants was not changed to other tumoricidal cells or soluble mediators, except that the macrophage-resistant variants were also resistant to the effects of another cytotoxic protein, B-cell lymphotoxin, which is structurally related to rTNF-alpha. Similar results were obtained regardless of whether short-term or long-term cytotoxic effects of aM phi were measured. Finally, it was shown that killing of tumor cells by murine aM phi was completely inhibited with a polyclonal antibody that neutralizes the effects of murine TNF-alpha. These results suggest a major role for TNF-alpha in tumor cell destruction by aM phi in vitro and in vivo.

摘要

活化巨噬细胞(aM phi)对癌细胞的破坏作用比正常细胞更有效。巨噬细胞破坏癌细胞的机制尚不清楚。我们在此报告,对aM phi敏感的肿瘤细胞可被重组(r)肿瘤坏死因子α(TNF-α)杀死,而在体外或体内筛选后对aM phi具有抗性的变异肿瘤细胞对rTNF-α的杀伤具有抗性。对rTNF-α抗性变异体进行反向筛选得到的细胞对aM phi的杀伤也具有抗性。除了巨噬细胞抗性变异体对另一种细胞毒性蛋白B细胞淋巴毒素的作用也具有抗性(B细胞淋巴毒素在结构上与rTNF-α相关)外,巨噬细胞抗性变异体对其他杀肿瘤细胞或可溶性介质的敏感性未发生改变。无论测量的是aM phi的短期还是长期细胞毒性作用,均可获得类似结果。最后,结果表明,用一种中和鼠TNF-α作用的多克隆抗体可完全抑制鼠aM phi对肿瘤细胞的杀伤。这些结果表明TNF-α在体外和体内aM phi对肿瘤细胞的破坏中起主要作用。

相似文献

4
Separation of soluble amoebicidal and tumoricidal activity of activated macrophages.
J Protozool. 1992 Jan-Feb;39(1):235-41. doi: 10.1111/j.1550-7408.1992.tb01307.x.
9
Characterization of 3LL-tumor variants generated by in vitro macrophage-mediated selection.
Int J Cancer. 1987 Mar 15;39(3):343-52. doi: 10.1002/ijc.2910390313.

引用本文的文献

2
Trastuzumab: dreams, desperation and hope.曲妥珠单抗:梦想、绝望与希望。
Nat Rev Cancer. 2024 May;24(5):287-288. doi: 10.1038/s41568-024-00676-9.
9
The expanding landscape of inflammatory cells affecting cancer therapy.影响癌症治疗的炎症细胞的扩展领域。
Nat Biomed Eng. 2020 May;4(5):489-498. doi: 10.1038/s41551-020-0524-y. Epub 2020 Mar 18.

本文引用的文献

9
Immunologic mechanisms in UV radiation carcinogenesis.紫外线辐射致癌中的免疫机制。
Adv Cancer Res. 1981;34:69-106. doi: 10.1016/s0065-230x(08)60239-0.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验